Randomized Controlled Trial of Olanzapine for the Control of Chemotherapy-induced Vomiting in Children Receiving Cyclophosphamide-based Conditioning for Allogeneic Hematopoietic Stem Cell Transplant

奥氮平控制接受基于环磷酰胺的同种异体造血干细胞移植调理的儿童化疗引起的呕吐的随机对照试验

• 批准号: 370131
• 负责人: Dupuis L. L
• 金额: $ 67.99万
• 依托单位: Hospital for Sick Children (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-09-01 至 2022-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=370131&lang=en
• 关键词: Chemotherapy-Induced Nausea; Chemotherapy-Induced Vomiting; Hematopoietic Stem Cell Transplant; Olanzapine; Oncology; Pediatric; Supportive Care

What do we know about this topic? Cancer patients, adults and children, are greatly distressed by vomiting due to chemotherapy. Vomiting due to chemotherapy is completely prevented in most adults with cancer by giving medicines called antiemetics. Antieme

关于这个话题我们知道些什么？癌症患者，无论是成人还是儿童，都因化疗引起的呕吐而感到非常痛苦。大多数成年癌症患者通过服用止吐药可以完全预防化疗引起的呕吐。Antieme